Infection Control and Disease Surveillance in Africa

By Crystal Lubbe

December 10, 2024

The topic of National borders as a critical frontline in containing deadly infections is increasingly significant for public health initiatives. The Africa CDC plays a crucial role in addressing infection prevention and control measures linked to these borders. Their approach emphasises the necessity of robust systems and collaborations that allow for effective management of health threats that cross national boundaries.

Infection Prevention and Control (IPC) Legal Framework

The Africa CDC has developed a comprehensive IPC Legal Framework aimed at strengthening infection prevention and control measures across African Union Member States. This framework incorporates six critical areas:
– Establishing national IPC programs
– Developing evidence-based guidance
– Training and educating personnel
– Conducting surveillance for healthcare-associated infections (HAIs)
– Developing systems to monitor compliance with laws
– Mandating specific staffing and infrastructure changes in hospitals.

Implementation and Support

The Africa CDC is actively assisting Member States in implementing this IPC Legal Framework through financial, technical, and collaborative support. Workshops and joint efforts with countries like Cameroon, Liberia, Malawi, and Nigeria have been conducted to review and enhance existing IPC programs and legal instruments.

Disease Surveillance and Health Security

In collaboration with the World Health Organization (WHO) and other partners, the Africa CDC has launched initiatives to strengthen disease surveillance and health security across Africa. This includes the Health Security Partnership designed to enhance integrated disease surveillance, event-based surveillance, genomic surveillance, and epidemic intelligence. Such partnerships are invaluable for swiftly detecting and addressing health security threats, especially since national borders serve as a critical frontline in containing deadly infections.

Cross-Border Disease Control

National borders are crucial in containing infections, making RISLNET vital. It harmonises labs, integrates surveillance, and boosts cross-border collaboration to combat regional health challenges.

Multi-Sectoral Collaboration

The Africa CDC promotes a multi-sectoral approach to align IPC measures with regional and international standards. This collaborative effort is crucial for effective implementation and fostering a healthier and safer environment across the continent.

In summary, the Africa CDC’s efforts in infection prevention and control, disease surveillance, and health security therefore, illustrate the vital role of National borders as a critical frontline in containing deadly infections. Their documented initiatives highlight the importance of robust legal frameworks, cross-border collaboration, and multi-sectoral approaches to effectively combat health threats.

Reference url

Recent Posts

Evolving Strategies in Type 2 Diabetes Management: NICE Guideline Update 2025

By Staff Writer

August 21, 2025

Type 2 diabetes management in adults is undergoing significant changes with the draft 2025 NICE guideline update. What are the main improvements in medication, monitoring, and patient care for adults with type 2 diabetes? The answer: The new NICE recommendations prioritize a broader use of SGL...
Guiding the Future of Digital Cardiac Rehabilitation: NICE’s Conditional Recommendations

By João L. Carapinha

August 20, 2025

The National Institute for Health and Care Excellence (NICE) has issued consultative draft guidance recommending six digital cardiac rehabilitation technologies for adults with cardiovascular disease (CVD). These technologies are conditionally recommended for use in the NHS during a three-year ev...
Assessment of Glofitamab With Gemcitabine in DLBCL Reveals No Additional Benefit

By João L. Carapinha

August 19, 2025

A recent G-BA decision provides a systematic evaluation of Glofitamab Gemcitabine DLBCL, combined with Gemcitabine and Oxaliplatin (GemOx), for treating adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who are ineligible for autologous stem cell transplantation. The review...